Insider trading

Period: 12 months Stock: BBNX Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

45 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

45 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

45 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

45 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
45 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
45 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

45 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
1 Oct 2026
Hopman Mark Chief Commercial Officer
Sold at will
$7.02K 370 at 18.96
0.7%
Not planned
22 Sep 2026
Jones Christy Director
Sold on a plan
$147.89K 6,430 at 23.00
24.7%
Planned (10b5-1)
16 Sep 2026
Hopman Mark Chief Commercial Officer
Sold on a plan
$619.64K 30,779 at 20.13
35.3%
Planned (10b5-1)
16 Sep 2026
Mensinger Mike Chief Product Officer
Sold on a plan
$58.30K 2,650 at 22.00
1.5%
Planned (10b5-1)
14 Sep 2026
Hopman Mark Chief Commercial Officer
Sold on a plan
$12.03K 775 at 15.52
0.9%
Planned (10b5-1)
9 Sep 2026
Hopman Mark Chief Commercial Officer
Sold on a plan
$680.72K 36,870 at 18.46
29.7%
Planned (10b5-1)
3 Sep 2026
Saint Sean President & CEO
Sold on a plan
$113.26K 5,641 at 20.08
1.4%
Planned (10b5-1)
2 Sep 2026
Saint Sean President & CEO
Sold at will
$322.38K 16,867 at 19.11
4.0%
Not planned
2 Sep 2026
Feider Stephen Chief Financial Officer
Sold at will
$127.58K 6,675 at 19.11
4.0%
Not planned
2 Sep 2026
Hopman Mark Chief Commercial Officer
Sold at will
$101.82K 5,327 at 19.11
4.1%
Not planned
2 Sep 2026
Mensinger Mike Chief Product Officer
Sold at will
$83.62K 4,375 at 19.11
2.4%
Not planned
2 Sep 2026
Russell Steven Jon Chief Medical Officer
Sold at will
$80.68K 4,221 at 19.11
2.4%
Not planned
29 Jun 2026
Feider Stephen Chief Financial Officer
Sold on a plan
$83.38K 4,896 at 17.03
2.9%
Planned (10b5-1)
26 Jun 2026
Feider Stephen Chief Financial Officer
Sold on a plan
$87.01K 5,104 at 17.05
3.0%
Planned (10b5-1)
24 Jun 2026
Jones Christy Director
Sold on a plan
$21.09K 1,406 at 15.00
5.1%
Planned (10b5-1)
24 Jun 2026
Hopman Mark Chief Commercial Officer
Sold on a plan
$18.88K 1,258 at 15.01
1.0%
Planned (10b5-1)
4 Jun 2026
Jones Christy Director
Sold on a plan
$39.35K 2,811 at 14.00
9.3%
Planned (10b5-1)
4 Jun 2026
Hopman Mark Chief Commercial Officer
Sold on a plan
$3.39K 275 at 12.31
0.2%
Planned (10b5-1)
2 Jun 2026
Saint Sean President & CEO
Sold at will
$212.71K 16,872 at 12.61
3.9%
Not planned
2 Jun 2026
Feider Stephen Chief Financial Officer
Sold at will
$84.16K 6,676 at 12.61
3.9%
Not planned
2 Jun 2026
Hopman Mark Chief Commercial Officer
Sold at will
$67.18K 5,329 at 12.61
3.9%
Not planned
2 Jun 2026
Mensinger Mike Chief Product Officer
Sold at will
$55.19K 4,378 at 12.61
2.3%
Not planned
2 Jun 2026
Russell Steven Jon Chief Medical Officer
Sold at will
$53.23K 4,222 at 12.61
2.4%
Not planned
22 May 2026
Lezack Adam Director
Sold on a plan
$11.19K 998 at 11.21
3.5%
Planned (10b5-1)
21 May 2026
Jones Christy Director
Sold on a plan
$19.88K 1,998 at 9.95
13.1%
Planned (10b5-1)
21 May 2026
Lezack Adam Director
Sold on a plan
$9.95K 1,000 at 9.95
8.0%
Planned (10b5-1)
4 Mar 2026
Hopman Mark Chief Commercial Officer
Sold on a plan
$4.08K 353 at 11.57
0.3%
Planned (10b5-1)
2 Mar 2026
Saint Sean President & CEO
Sold at will
$41.83K 3,384 at 12.36
0.8%
Not planned
2 Mar 2026
Feider Stephen Chief Financial Officer
Sold at will
$17.65K 1,428 at 12.36
0.8%
Not planned
2 Mar 2026
Mensinger Mike Chief Product Officer
Sold at will
$13.15K 1,064 at 12.36
0.6%
Not planned
2 Mar 2026
Russell Steven Jon Chief Medical Officer
Sold at will
$12.68K 1,026 at 12.36
0.6%
Not planned
2 Mar 2026
Hopman Mark Chief Commercial Officer
Sold at will
$10.31K 834 at 12.36
0.6%
Not planned
6 Jan 2026
Mensinger Mike Chief Product Officer
Sold on a plan
$66.22K 2,200 at 30.10
2.7%
Planned (10b5-1)
2 Jan 2026
Feider Stephen Chief Financial Officer
Sold on a plan
$590.68K 20,000 at 29.53
31.9%
Planned (10b5-1)
2 Jan 2026
Mensinger Mike Chief Product Officer
Sold on a plan 2×
$230.95K 7,800 at 29.61
8.6%
Planned (10b5-1)
4 Dec 2025
Hopman Mark Chief Commercial Officer
Sold on a plan
$63.19K 2,061 at 30.66
1.5%
Planned (10b5-1)
2 Dec 2025
Saint Sean President & CEO
Sold at will
$96.16K 3,278 at 29.34
3.2%
Not planned
2 Dec 2025
Feider Stephen Chief Financial Officer
Sold at will
$41.86K 1,427 at 29.34
3.2%
Not planned
2 Dec 2025
Mensinger Mike Chief Product Officer
Sold at will
$31.18K 1,063 at 29.34
1.2%
Not planned
2 Dec 2025
Russell Steven Jon Chief Medical Officer
Sold at will
$30.07K 1,025 at 29.34
0.6%
Not planned
2 Dec 2025
Hopman Mark Chief Commercial Officer
Sold on a plan
$25.11K 856 at 29.34
0.6%
Planned (10b5-1)
1 Dec 2025
Palasis Maria Director
Sold on a plan 2×
$41.55K 1,406 at 29.55
14.3%
Planned (10b5-1)
1 Dec 2025
Lezack Adam Director
Sold on a plan 2×
$41.54K 1,406 at 29.55
14.3%
Planned (10b5-1)
31 Oct 2025
Palasis Maria Director
Sold on a plan 2×
$37.83K 1,406 at 26.91
12.5%
Planned (10b5-1)
31 Oct 2025
Lezack Adam Director
Sold on a plan 2×
$37.78K 1,406 at 26.87
12.5%
Planned (10b5-1)
Showing 1–45 of 45.